Xylem Inc.
107.64USD
-1.1700 (-1.08%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 5.5B | 7.4B | 8.6B | 9.0B | 9.2B | 9.6B |
| Q1 | 1.3B | 1.4B | 2.0B | 2.1B | 2.1B | — |
| Q2 | 1.4B | 1.7B | 2.2B | 2.3B | 2.3B | — |
| Q3 | 1.4B | 2.1B | 2.1B | 2.3B | 2.3B | — |
| Q4 | 1.5B* | 2.1B* | 2.3B* | 2.4B* | 2.5B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 1.96 | 2.79 | 3.65 | 3.92 | 5.66 | 6.25 |
| Q1 | .450 | .540 | .630 | .690 | .790 | — |
| Q2 | .620 | .450 | .800 | .930 | 1.11 | — |
| Q3 | .070 | .630 | .890 | .930 | 1.45 | — |
| Q4 | .823* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 1.22* |
| 1.34* |
| 1.37* |
| 1.65 |
| — |